Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The 14-3-3 protein test has been shown to support the clinical diagnosis of sporadic Creutzfeldt-Jakob disease (CJD) when associated with an adequate clinical context, and a high differential potential for the diagnosis of sporadic CJD has been attributed to other cerebrospinal fluid (CSF) proteins such as tau protein, S100b and neuron specific enolase (NSE). So far there has been only limited information available about biochemical markers in genetic transmissible spongiform encephalopathies (gTSE), although they represent 10-15% of human TSEs. In this study, we analyzed CSF of 174 patients with gTSEs for 14-3-3 (n = 166), tau protein (n = 78), S100b (n = 46) and NSE (n = 50). Levels of brain-derived proteins in CSF varied in different forms of gTSE. Biomarkers were found positive in the majority of gCJD (81%) and insert gTSE (69%), while they were negative in most cases of fatal familial insomnia (13%) and Gerstmann-Sträussler-Scheinker syndrome (10%). Disease duration and codon 129 genotype influence the findings in a different way than in sporadic CJD.

Original publication

DOI

10.1007/s00415-009-5163-x

Type

Journal article

Journal

J Neurol

Publication Date

10/2009

Volume

256

Pages

1620 - 1628

Keywords

14-3-3 Proteins, Adult, Aged, Aged, 80 and over, Biomarkers, Creutzfeldt-Jakob Syndrome, Female, Genotype, Gerstmann-Straussler-Scheinker Disease, Humans, Insomnia, Fatal Familial, Male, Middle Aged, Nerve Growth Factors, Phosphopyruvate Hydratase, Prion Diseases, S100 Calcium Binding Protein beta Subunit, S100 Proteins, Time Factors, Young Adult, tau Proteins